Riskpilot← Back to searchSign inGet full accessNEUCLEUS AS
ASIn liquidationOrg 916224540Bygdøy allé 4, 0257 OsloRental and operating of own or leased real estate · NACE 6820Est. 20150 employees
Revenue 2024
NOK 869K
+1% vs 2023
EBITDA margin
-12.9%
-29% vs 2023
Equity ratio
96.9%
Financial strength
Net profit 2024
NOK -88K
-17% vs 2023
| Revenue | NOK 869K | +1% |
| EBITDA | NOK -112K | -29% |
| Net profit | NOK -88K | -17% |
| Total assets | NOK 978K | -7% |
| Equity | NOK 948K | -8% |
| Employees | 0 | — |
Legal name
NEUCLEUS AS
Org number
916224540
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
15. desember 2015
Share capital
NOK 1 900 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Leie, fremleie og utleie av fast eiendom.
Address
Bygdøy allé 4, 0257 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 696 | 693 | 726 | 726 | 727 | 771 | 764 | 864 | 869 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −7 | −1 042 | −19 | −42 | −56 | −108 | −67 | −164 | −87 | −112 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −7 | −1 042 | −19 | −42 | −56 | −108 | −67 | −164 | −87 | −112 |
| Net financials | 0 | 10 | 17 | 15 | 16 | 7 | 2 | 3 | 12 | 25 |
| Profit before tax | −7 | −1 032 | −1 | −27 | −40 | −101 | −65 | −161 | −75 | −88 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −7 | −1 032 | −1 | −27 | −40 | −101 | −65 | −161 | −75 | −88 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 45 | 1 520 | 1 514 | 1 486 | 1 476 | 1 340 | 1 274 | 1 116 | 1 052 | 978 |
| Equity | 38 | 1 506 | 1 505 | 1 478 | 1 438 | 1 337 | 1 271 | 1 110 | 1 035 | 948 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 | 13 | 9 | 8 | 38 | 3 | 3 | 6 | 17 | 31 |
| Total debt | 7 | 13 | 9 | 8 | 38 | 3 | 3 | 6 | 17 | 31 |
EBITDA margin
-12.9%
This company
15.8%
Market median
-182% vs market
20152024
Equity ratio
96.9%
This company
38.2%
Market median
+154% vs market
20152024
Return on equity
-9.2%
This company
18.4%
Market median
-150% vs market
20152024
Net profit margin
-10.1%
This company
8.1%
Market median
-225% vs market
20152024
Asset turnover
0.89×
This company
1.12×
Market median
+21% vs market
20152024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20152024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2014-10-22 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SG Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2015 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2015 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NEUCLEUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sirianne Guslund Haavik | Chief Executive Officer | 0 companies |
| Anne Catrine Møller | Chairman | 0 companies |
| Mette Burkeland | Board of Directors | 0 companies |
| Jan Arne Tønsberg | Board of Directors | 0 companies |